Do BRAF inhibitors select for populations with different disease progression kinetics?

by Ascierto, Paolo Antonio, Simeone, Ester, Grimaldi, Antonio Maria, Curvietto, Marcello, Esposito, Assunta, Palmieri, Giuseppe, Mozzillo, Nicola
Published 2013

Serious haematological toxicity during and after ipilimumab treatment: a case series

by Simeone, Ester, Grimaldi, Antonio Maria, Esposito, Assunta, Curvietto, Marcello, Palla, Marco, Paone, Miriam, Mozzillo, Nicola, Ascierto, Paolo Antonio
Published 2014

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab

by Bifulco, Carlo, Capone, Marilena, Feng, Zip, Madonna, Gabriele, Simeone, Ester, Curvietto, Marcello, Mozzillo, Nicola, Ciliberto, Gennaro, Botti, Gerardo, Fox, Bernard A, Ascierto, Paolo A
Published 2014

Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma

by Simeone, Ester, Grimaldi, Antonio Maria, Festino, Lucia, Giannarelli, Diana, Vanella, Vito, Palla, Marco, Curvietto, Marcello, Esposito, Assunta, Palmieri, Giuseppe, Mozzillo, Nicola, Ascierto, Paolo Antonio
Published in Oncoimmunology (2017)

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients

by Grimaldi, Antonio Maria, Simeone, Ester, Festino, Lucia, Giannarelli, Diana, Palla, Marco, Caracò, Corrado, Curvietto, Marcello, Esposito, Assunta, Grimaldi, Maria Chiara, Mozzillo, Nicola, Ascierto, Paolo A
Published in J Immunother Cancer (2015)

Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients

by Simeone, Ester, Grimaldi, Antonio Maria, Festino, Lucia, Giannarelli, Diana, Palla, Marco, Caracò, Corrado, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Rinaldi, Giovanni, Grimaldi, Maria Chiara, Mozzillo, Nicola, Ascierto, Paolo A
Published in J Immunother Cancer (2015)

The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

by Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Palla, Marco, Muto, Paolo, Falivene, Sara, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Published 2013

Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

by Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Muto, Paolo, Falivene, Sara, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Palla, Marco, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Published 2014

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib

by Queirolo, Paola, Spagnolo, Francesco, Picasso, Virginia, Spano, Laura, Tanda, Enrica, Fontana, Valeria, Giorello, Laura, Merlo, Domenico Franco, Simeone, Ester, Grimaldi, Antonio Maria, Curvietto, Marcello, Del Vecchio, Michele, Bruzzi, Paolo, Ascierto, Paolo Antonio
Published in Oncotarget (2016)

BRAF Gene and Melanoma: Back to the Future

by Ottaviano, Margaret, Giunta, Emilio Francesco, Tortora, Marianna, Curvietto, Marcello, Attademo, Laura, Bosso, Davide, Cardalesi, Cinzia, Rosanova, Mario, De Placido, Pietro, Pietroluongo, Erica, Riccio, Vittorio, Mucci, Brigitta, Parola, Sara, Vitale, Maria Grazia, Palmieri, Giovannella, Daniele, Bruno, Simeone, Ester
Published in Int J Mol Sci (2021)

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

by Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Muto, Paolo, Falivene, Sara, Borzillo, Valentina, Giugliano, Francesca Maria, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Palla, Marco, Palmieri, Giuseppe, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Published 2014

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

by Mozzillo, Nicola, Simeone, Ester, Benedetto, Lucia, Curvietto, Marcello, Giannarelli, Diana, Gentilcore, Giusy, Camerlingo, Rosa, Capone, Mariaelena, Madonna, Gabriele, Festino, Lucia, Caracò, Corrado, Di Monta, Gianluca, Marone, Ugo, Di Marzo, Massimiliano, Grimaldi, Antonio M, Mori, Stefano, Ciliberto, Gennaro, Ascierto, Paolo A
Published in Oncoimmunology (2015)

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

by Simeone, Ester, Scognamiglio, Giosuè, Capone, Mariaelena, Giannarelli, Diana, Grimaldi, Antonio M., Mallardo, Domenico, Madonna, Gabriele, Curvietto, Marcello, Esposito, Assunta, Sandomenico, Fabio, Sabbatino, Francesco, Bayless, Nicholas L., Warren, Sarah, Ong, SuFey, Botti, Gerardo, Flaherty, Keith T., Ferrone, Soldano, Ascierto, Paolo A.
Published in J Transl Med (2021)

High expression of a spliced variant of FKBP51 in peripheral blood mononuclear cells of melanoma patients may be related to PDL-1 on tumour and predictive of response to Ipilimumab

by Simeone, Ester, Romano, Maria fiammetta, Grimaldi, Antonio Maria, Esposito, Assunta, Curvietto, Marcello, Paone, Miriam, Rinaldi, Giovanni, Di monta, Gianluca, Di marzo, Massimiliano, Hauber, Federica, Festino, Lucia, D'Angelillo, Anna, Romano, Simona, Staibano, Stefania, Ilardi, Gennaro, Bisogni, Rita, Mozzillo, Nicola, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2014)

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology

by Pascarella, Giacomo, Capasso, Arturo, Nardone, Antonio, Triassi, Maria, Pignata, Sandro, Arenare, Laura, Ascierto, Paolo, Curvietto, Marcello, Maiolino, Piera, D’Aniello, Roberta, Montanino, Agnese, Laudato, Francesca, De Feo, Gianfranco, Botti, Gerardo, Perrone, Francesco, Petrillo, Antonella, Cavalcanti, Ernesta, Lastoria, Secondo, Maurea, Nicola, Morabito, Alessandro
Published in PLoS One (2019)

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

by Montesarchio, Vincenzo, Parrella, Roberto, Iommelli, Chiara, Bianco, Antonella, Manzillo, Elio, Fraganza, Fiorentino, Palumbo, Cristiana, Rea, Gaetano, Murino, Patrizia, De Rosa, Rosanna, Atripaldi, Luigi, D’Abbraccio, Maurizio, Curvietto, Marcello, Mallardo, Domenico, Celentano, Egidio, Grimaldi, Antonio Maria, Palla, Marco, Trojaniello, Claudia, Vitale, Maria Grazia, Million-Weaver, Samuel Lewis, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2020)

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

by Isgrò, Maria Antonietta, Vitale, Maria Grazia, Celentano, Egidio, Nocerino, Flavia, Porciello, Giuseppe, Curvietto, Marcello, Mallardo, Domenico, Montagnese, Concetta, Russo, Luigi, Zanaletti, Nicoletta, Avallone, Antonio, Pensabene, Matilde, De Laurentiis, Michelino, Centonze, Sara, Pignata, Sandro, Cannella, Lucia, Morabito, Alessandro, Caponigro, Francesco, Botti, Gerardo, Masucci, Giuseppe Valentino, Giannarelli, Diana, Cavalcanti, Ernesta, Ascierto, Paolo Antonio
Published in J Transl Med (2021)

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists

by Ottaviano, Margaret, Curvietto, Marcello, Rescigno, Pasquale, Tortora, Marianna, Palmieri, Giovannella, Giannarelli, Diana, Aieta, Michele, Assalone, Pasquale, Attademo, Laura, Avallone, Antonio, Bloise, Francesco, Bosso, Davide, Borzillo, Valentina, Buono, Giuseppe, Calderoni, Giuseppe, Caputo, Francesca, Cartenì, Giacomo, Cavallero, Diletta, Cavo, Alessia, Ciardiello, Fortunato, Conca, Raffaele, Conteduca, Vincenza, De Falco, Stefano, De Felice, Marco, De Laurentiis, Michelino, De Placido, Pietro, De Placido, Sabino, De Santo, Irene, De Stefano, Alfonso, Della Corte, Carminia Maria, Di Franco, Rossella, Di Lauro, Vincenzo, Fabbrocini, Antonietta, Federico, Piera, Festino, Lucia, Giordano, Pasqualina, Giuliano, Mario, Gridelli, Cesare, Grimaldi, Antonio Maria, Lia, Michela, Marretta, Antonella Lucia, Massa, Valentina, Mennitto, Alessia, Merler, Sara, Merz, Valeria, Messina, Carlo, Messina, Marco, Milano, Monica, Minisini, Alessandro Marco, Montesarchio, Vincenzo, Morabito, Alessandro, Morgillo, Floriana, Mucci, Brigitta, Nappi, Lucia, Napolitano, Fabiana, Paciolla, Immacolata, Pagliuca, Martina, Palmieri, Giuseppe, Parola, Sara, Pepe, Stefano, Petrillo, Angelica, Piantedosi, Francovito, Piccin, Luisa, Picozzi, Fernanda, Pietroluongo, Erica, Pignata, Sandro, Prati, Veronica, Riccio, Vittorio, Rosanova, Mario, Rossi, Alice, Russo, Anna, Salati, Massimiliano, Santabarbara, Giuseppe, Sbrana, Andrea, Simeone, Ester, Silvestri, Antonia, Spada, Massimiliano, Tarantino, Paolo, Taveggia, Paola, Tomei, Federica, Vincenzo, Tortora, Trapani, Dario, Trojanello, Claudia, Vanella, Vito, Vari, Sabrina, Ventriglia, Jole, Vitale, Maria Grazia, Vitiello, Fabiana, Vivaldi, Caterina, von Arx, Claudia, Zacchi, Francesca, Zampiva, Ilaria, Zivi, Andrea, Daniele, Bruno, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2020)